C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2011
12/06/2011	US8071371 Monoclonal antibody production by EBV transformation of B cells
12/06/2011	US8071369 Compositions for reprogramming somatic cells
12/06/2011	US8071368 Methods for promoting growth and survival of insulin-secreting cells
12/06/2011	US8071367 Selecting, culturing and creating lineage committed hematopoietic stem cells
12/06/2011	US8071366 Neural progenitor cells derived from whole bone marrow
12/06/2011	US8071364 Gene therapy using transposon-based vectors
12/06/2011	US8071349 BGL4 beta-glucosidase and nucleic acids encoding the same
12/06/2011	US8071348 Replacing aspartate and glutamine residues with alanine causes reduction in catalytic rate and increases substrate binding affinity; kits; drug screening
12/06/2011	US8071333 Anti-integrin antibodies, compositions, methods and uses
12/06/2011	US8071332 Recombinant mammal cells, method of producing thereof, and method of producing proteins of interest
12/06/2011	US8071323 Human monoclonal antibodies that bind human insulin like growth factors and their use
12/06/2011	US8071294 Cancer therapy sensitizer
12/06/2011	US8071292 Leukemia diagnostic methods
12/06/2011	US8071281 Media solutions and methods for cryopreservation and thawing of in vitro fertilization specimens
12/06/2011	US8071280 Media solutions and methods for cryopreservation and thawing of in vitro fertilization specimens
12/06/2011	US8071107 Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins
12/06/2011	US8071102 Methods to clear meningitis causing agents using antibodies to peptides representing epitopic sites for bacterial and viral meningitis causing agents
12/06/2011	US8071099 Anti-FLT3 antibodies
12/06/2011	US8071096 Anti-C5aR antibodies and uses thereof
12/06/2011	US8071085 adipocytes stably maintain a foreign gene encoding a protein that is secreted outside of cells; cells suitable for gene therapy, which can replace bone marrow cells and liver cells used for conventional ex vivo gene therapy
12/06/2011	US8071083 Tissue regeneration
12/06/2011	US8071074 e.g. (6,7-(dimethoxyquinazolin-4-yl)-(3-ethynylphenyl)-amine; epidermal growth factor receptor (EGF-R) antagonist, tyrosine kinase inhibitor; hypersecretion of mucus in lungs: chronic bronchitis, acute asthma, cystic fibrosis, bronchiectasis, chronic obstructive lung disease
12/06/2011	CA2734759C High yielding soybean variety 93y22
12/06/2011	CA2734233C High yielding soybean variety xb32ar11
12/06/2011	CA2734229C High yielding soybean variety xb28ad11
12/06/2011	CA2734226C High yielding soybean variety xb31b11
12/06/2011	CA2734159C High yielding soybean variety xb12b11
12/06/2011	CA2734022C High yielding soybean variety 91y41
12/06/2011	CA2734019C High yielding soybean variety 90y21
12/06/2011	CA2734018C High yielding soybean variety xr29t10
12/06/2011	CA2734009C High yielding soybean variety 92y73
12/06/2011	CA2733999C High yielding soybean variety xb009e11
12/06/2011	CA2733998C High yielding soybean variety 90y90
12/06/2011	CA2733993C High yielding soybean variety xb30al11
12/06/2011	CA2733983C High yielding soybean variety xb31e11
12/06/2011	CA2733949C High yielding soybean variety xb009k11
12/06/2011	CA2733888C High yielding soybean variety xr15t10
12/06/2011	CA2733884C High yielding soybean variety 91y61
12/06/2011	CA2733883C High yielding soybean variety 92y12
12/06/2011	CA2701074C High yielding, early soybean variety 90y30
12/06/2011	CA2701073C High yielding, phytophthora resistant, early soybean variety 90y70
12/06/2011	CA2700834C High yielding, soybean cyst nematode and phytophthora resistant soybean variety 93y05
12/06/2011	CA2700789C High yielding soybean variety 91y22
12/06/2011	CA2700146C High yielding, phytophthora root rot resistant, early soybean variety 900y71
12/06/2011	CA2620766C Stress-induced transcription factor derived from maize
12/06/2011	CA2579643C Medium and culture of embryonic stem cells
12/06/2011	CA2490693C Gene regulation in transgenic animals using a transposon-based vector
12/06/2011	CA2486759C Universal chimera bank
12/06/2011	CA2473163C Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies
12/06/2011	CA2461141C Keratinocytes which may be used as a biologically active substance in the treatment of wounds
12/06/2011	CA2370867C Use of glucose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
12/06/2011	CA2345287C Tgf-beta superfamily mutant members, including morphogenic proteins
12/06/2011	CA2328783C Human procalcitonin and the preparation and use thereof
12/06/2011	CA2305683C Immunogenic peptides from the hpv e7 protein
12/06/2011	CA2299609C Universal chloroplast integration and expression vectors, transformed plants and products thereof
12/04/2011	CA2742005A1 Transgenic brassica event mon 88302 and methods of use thereof
12/01/2011	WO2011150398A1 Compositions and methods of using living and non-living bioactive devices with components derived from self- renewing colony forming cells cultured and expanded in vitro
12/01/2011	WO2011150375A2 Endothelial colony forming cell culture medium
12/01/2011	WO2011150347A2 Non-peptide bdnf neurotrophin mimetics
12/01/2011	WO2011150033A1 Enteroendocrine manipulation for metabolic effect
12/01/2011	WO2011149762A2 Method of nociceptor differentiantion of human embryonic stem cells and uses thereof
12/01/2011	WO2011149743A1 Multiply fluorescently labeled calcium phosphate-protein surfaces
12/01/2011	WO2011149741A1 Fluorescently labeled calcium phosphate surfaces
12/01/2011	WO2011149529A2 Cell-based preparations for wound management
12/01/2011	WO2011149389A1 An immunogenic composition for treatment of hepatitis c, a method for preparing the composition and use thereof for treating hepatitis c
12/01/2011	WO2011149352A1 Osteoarthrosis markers
12/01/2011	WO2011149108A1 Treated cell for accelerating regeneration of biotissue
12/01/2011	WO2011149102A1 Highly immunodeficient mouse optimized for bioimaging
12/01/2011	WO2011148996A1 Liquid culture medium for substance introduction and method for introducing substance into cell
12/01/2011	WO2011148983A1 Induced malignant stem cells or pre-induction cancer stem cells capable of self-replication outside of an organism, production method for same, and practical application for same
12/01/2011	WO2011148938A1 Protein having diaphorase activity
12/01/2011	WO2011148326A1 Virally-inactivated growth factors-containing platelet lysate depleted of pdgf and vegf and preparation method thereof
12/01/2011	WO2011148310A1 Method for culturing adipocytes
12/01/2011	WO2011148025A1 Biomarker for cartilaginous human cells
12/01/2011	WO2011147967A1 Skeletal muscle regeneration using mesenchymal stem cells
12/01/2011	WO2011147930A1 Thermoresponsive multi-layer substrate for biological cells
12/01/2011	WO2011147622A1 Antigen-presenting modified naïve b cells for immune suppression and a method for producing said modified cells
12/01/2011	WO2011147452A1 Method for preparing a degradable polymer network
12/01/2011	WO2011147138A1 Targeting fusion protein of interleukin and preparation method and use thereof
12/01/2011	WO2011147119A1 Cryoprotectant solution for non-programmed cell cryopreservation
12/01/2011	WO2011147118A1 Non-programmed protein-free cell cryopreservation medium
12/01/2011	WO2011147057A1 Anti-angiogenic fusion polypeptide, gene and use thereof
12/01/2011	WO2011117756A3 Cultured tobacco cells as a matrix for consumable products
12/01/2011	WO2011111787A8 Cell preparation containing mesenchymal stem cells, and method for producing same
12/01/2011	WO2011103247A3 Axmi218, axmi219, axmi220, axmi226, axmi227, axmi228, axmi229, axmi230, and axmi231 delta-endotoxin genes and methods for their use
12/01/2011	WO2011097242A3 Methods of isolating and culturing mesenchymal stem cells
12/01/2011	WO2011086143A3 Liver targeting domain antibodies
12/01/2011	WO2011085157A3 Methods for in vitro oocyte maturation
12/01/2011	WO2011083478A3 Methods of loading cells
12/01/2011	WO2011054929A3 Method for producing triptolide
12/01/2011	US20110296560 Wheat starch and wheat flours and foodstuffs containing these wheat starch/wheat flours
12/01/2011	US20110296559 Crispers lettuce variety
12/01/2011	US20110296558 Polypeptides having expansin Activity and Polynucleotides Encoding Same
12/01/2011	US20110296557 Polypeptides Having Lipase Activity And Polynucleotides Encoding Same
12/01/2011	US20110296556 Polynucleotide molecules for gene regulation in plants
12/01/2011	US20110296555 Recombinant DNA Constructs and Methods for Modulating Expression of a Target Gene
12/01/2011	US20110296554 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment
12/01/2011	US20110296553 Engineering broad and durable resistance to grapevine fanleaf virus in plants
12/01/2011	US20110296552 Expression cassettes for seed-specific expression in plants
12/01/2011	US20110296551 Plant mitochondria transformation method

1 ... 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 ... 1827